مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

9,350
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

EVALUATING THE EFFECTS OF PROSTATAN AS AN ADJUNCT DRUG IN TREATMENT OF BENIGN PROSTATIC HYPERPLASIA

Pages

  78-87

Abstract

 Introduction: BENIGN PROSTATIC HYPERPLASIA (BPH) is the most common benign tumor in men. Due to the side effects of chemical drugs, phytotherapy has become a treatment method in BPH since 1990s. PROSTATAN is a plant extract widely available in Iran. In this study, we evaluated the therapeutic effects of PROSTATAN drop in combination with PRAZOSIN in alleviating BPH symptoms.Materials and Methods: In a single blind randomized clinical trial, 66 men over 50 years with BPH symptoms who were visited in Vali-e-Asr hospital of Arak were randomly divided in two groups and treated with either PROSTATAN (40 drop, TDS) plus PRAZOSIN (1mg, BD) or PRAZOSIN (1mg, BD) alone . AUA symptom score, PSA (prostate-specific antigen) levels, Prostate volume, post voidal residue (PVR) by sonograms and uroflowmetry results were determined before and 12 weeks after treatment. Data was analyzed by T and Man- Whithey u tests.Results: Before treatment there were no significant differences in age, PSA, PVR, AUA symptom score, Prostate volume and uroflowmetry between the two groups. After treatment the mean of PSA levels, Prostate volume and PVR did not differ between the two groups. In the PROSTATAN plus PRAZOSIN group, the mean of AUA symptom score was 3.3 less (p<0.0001) and the mean of maximal URINE FLOW RATE was 2.7 ml/s more than the PRAZOSIN group (p<0.001).Conclusion: Regarding results, it seems that adding PROSTATAN to PRAZOSIN against PRAZOSIN alone enhances its effects on controlling BPH symptoms and increases URINE FLOW RATEs.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    GOUDARZI, DAVOUD, SIROUS, A., BAGHERINIA, M.A., AZIMI SHAHRABI, E., DELAVAR, M., & ARIAN FAR, F.. (2007). EVALUATING THE EFFECTS OF PROSTATAN AS AN ADJUNCT DRUG IN TREATMENT OF BENIGN PROSTATIC HYPERPLASIA. ARAK MEDICAL UNIVERSITY JOURNAL (AMUJ), 9(4 (37)), 78-87. SID. https://sid.ir/paper/69833/en

    Vancouver: Copy

    GOUDARZI DAVOUD, SIROUS A., BAGHERINIA M.A., AZIMI SHAHRABI E., DELAVAR M., ARIAN FAR F.. EVALUATING THE EFFECTS OF PROSTATAN AS AN ADJUNCT DRUG IN TREATMENT OF BENIGN PROSTATIC HYPERPLASIA. ARAK MEDICAL UNIVERSITY JOURNAL (AMUJ)[Internet]. 2007;9(4 (37)):78-87. Available from: https://sid.ir/paper/69833/en

    IEEE: Copy

    DAVOUD GOUDARZI, A. SIROUS, M.A. BAGHERINIA, E. AZIMI SHAHRABI, M. DELAVAR, and F. ARIAN FAR, “EVALUATING THE EFFECTS OF PROSTATAN AS AN ADJUNCT DRUG IN TREATMENT OF BENIGN PROSTATIC HYPERPLASIA,” ARAK MEDICAL UNIVERSITY JOURNAL (AMUJ), vol. 9, no. 4 (37), pp. 78–87, 2007, [Online]. Available: https://sid.ir/paper/69833/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top